As of June 30, 2026, Roche Holding Ltd carries a market capitalization of 248.63B, placing it among publicly traded companies globally. Its enterprise value stands at 276.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 248.63B |
| Enterprise Value | 276.91B |
As of June 30, 2026, Roche Holding Ltd has 690.07M shares outstanding.
| Shares Outstanding | 690.07M |
These figures are as of June 30, 2026.
| PB Ratio | 7.02 |
| P/TBV Ratio | 40.95 |
As of June 30, 2026, Roche Holding Ltd maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.23 |
| Quick Ratio | 0.34 |
| Debt / Equity | 86.62 |
As of the close on October 6, 2026, Roche Holding Ltd's stock has gained approximately 18.66% over the past 52 weeks. The 50-day moving average sits at 384.00, while the 200-day moving average is 369.47.
| 52-Week Price Change | 18.66% |
| 50-Day Moving Average | 384.00 |
| 200-Day Moving Average | 369.47 |
As of June 30, 2026, Roche Holding Ltd holds 10.55B in cash and equivalents against 34.46B in total debt, resulting in a net debt position of 28.56B. Total book value stands at 35.42B, with working capital of 7.14B providing operational flexibility.
| Cash & Cash Equivalents | 10.55B |
| Total Debt | 34.46B |
| Net Debt | 28.56B |
| Equity (Book Value) | 35.42B |
| Book Value Per Share | 51.33 |
| Working Capital | 7.14B |
Roche Holding Ltd's most recent stock split took place on May 4, 2001 with a 1:100 split ratio.
| Last Split Date | 5/4/2001 |
| Split Ratio | 1:100 |
Already premium?